(Q40834298)

24 September 2017

1 reference

title

Is there a future for antiarrhythmic drug therapy? (English)

1 reference

24 September 2017

Guerra PG

1

1 reference

24 September 2017

Talajic M

2

1 reference

24 September 2017

Roy D

3

1 reference

24 September 2017

Dubuc M

4

1 reference

24 September 2017

Thibault B

5

1 reference

24 September 2017

Nattel S

6

1 reference

24 September 2017

publication date

1 November 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

56

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

767-781

1 reference

The surgical treatment of atrial fibrillation. IV. Surgical technique

24 September 2017

cites work

1 reference

12 December 2020

Radiofrequency current catheter ablation of accessory atrioventricular pathways

1 reference

12 December 2020

Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness

1 reference

12 December 2020

Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance

1 reference

12 December 2020

A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia

1 reference

12 December 2020

Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test

1 reference

12 December 2020

Radiofrequency ablation for atrioventricular node reentrant tachycardia: comparison between fast (anterior) and slow (posterior) pathway ablation

1 reference

12 December 2020

Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone

1 reference

12 December 2020

Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death

1 reference

12 December 2020

Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm

1 reference

12 December 2020

Clinical safety profile of sotalol in patients with arrhythmias

1 reference

12 December 2020

Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia

1 reference

12 December 2020

Closed-chest ablation of retrograde conduction in patients with atrioventricular nodal reentrant tachycardia

1 reference

12 December 2020

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

12 December 2020

Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia.

1 reference

12 December 2020

Selective radiofrequency catheter ablation of fast and slow pathways in 100 patients with atrioventricular nodal reentrant tachycardia

1 reference

12 December 2020

Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil

1 reference

12 December 2020

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

12 December 2020

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

1 reference

12 December 2020

Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group

1 reference

12 December 2020

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

1 reference

12 December 2020

Molecular genetics of long QT syndrome from genes to patients

1 reference

12 December 2020

Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Verapamil or adenosine for the immediate treatment of supraventricular tachycardia.

1 reference

12 December 2020

Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil

1 reference

12 December 2020

Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil

1 reference

12 December 2020

Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

12 December 2020

Proarrhythmia in patients treated for atrial fibrillation or flutter

1 reference

12 December 2020

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

12 December 2020

Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Part III. Adult advanced cardiac life support

1 reference

12 December 2020

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

1 reference

12 December 2020

Polymorphous ventricular tachycardia associated with acute myocardial infarction

1 reference

12 December 2020

Successful Catheter Ablation of Atrial Fibrillation

1 reference

12 December 2020

Conversion of supraventricular arrhythmias to sinus rhythm using flecainide

1 reference

12 December 2020

The effects of ouabain on induction of atrioventricular nodal re-entrant paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle

1 reference

12 December 2020

Amiodarone in the management of refractory atrial fibrillation

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction.

1 reference

12 December 2020

"Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients

1 reference

12 December 2020

Therapeutic efficacy and safety of oral propafenone for atrial fibrillation

1 reference

12 December 2020

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

1 reference

12 December 2020

Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances

1 reference

12 December 2020

Newer developments in the management of atrial fibrillation.

1 reference

12 December 2020

Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide

1 reference

12 December 2020

Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide

1 reference

12 December 2020

Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group

1 reference

12 December 2020

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

12 December 2020

Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.

1 reference

12 December 2020

Electrical reversion of cardiac arrhythmias

1 reference

12 December 2020

Cardioversion and defibrillation

1 reference

12 December 2020

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

1 reference

12 December 2020

Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias

1 reference

12 December 2020

Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group

1 reference

12 December 2020

Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia

1 reference

12 December 2020

Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog

1 reference

12 December 2020

Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes

1 reference

12 December 2020

Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias

1 reference

12 December 2020

Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation

1 reference

12 December 2020

The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators

1 reference

12 December 2020

Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size

1 reference

12 December 2020

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators

1 reference

12 December 2020

The effects of propranolol on induction of A-V nodal reentrant paroxysmal tachycardia.

1 reference

12 December 2020

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

1 reference

12 December 2020

What is an antiarrhythmic drug? From clinical trials to fundamental concepts

1 reference

12 December 2020

Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents

1 reference

12 December 2020

Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias

1 reference

12 December 2020

Ventricular tachycardia: pathophysiology and radiofrequency catheter ablation

1 reference

12 December 2020

Oral Flecainide, Sotalol, and Verapamil for the Termination of Paroxysmal Supraventricular Tachycardia

1 reference

12 December 2020

A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group

1 reference

12 December 2020

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

1 reference

12 December 2020

Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction

1 reference

12 December 2020

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

1 reference

12 December 2020

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

12 December 2020

Standby automatic defibrillator. An approach to prevention of sudden coronary death

1 reference

12 December 2020

Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group

1 reference

12 December 2020

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

1 reference

12 December 2020

Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current

1 reference

12 December 2020

Verapamil reduces tachycardia-induced electrical remodeling of the atria

1 reference

12 December 2020

Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation

1 reference

12 December 2020

Management of ventricular fibrillation outside hospital

1 reference

12 December 2020

Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens

1 reference

12 December 2020

Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group

1 reference

12 December 2020

Clinical features and basic mechanisms of quinidine-induced arrhythmias

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation

1 reference

12 December 2020

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

12 December 2020

The future role of defibrillators in the management of atrial fibrillation.

1 reference

12 December 2020

The coronary care unit. New perspectives and directions

1 reference

12 December 2020

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

12 December 2020

Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug

1 reference

12 December 2020

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

12 December 2020

Ventricular fibrillation precipitated by cardiac catheterization; complete recovery of the patient after 45 minutes

1 reference

12 December 2020

Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study

1 reference

12 December 2020

Recent advances in understanding the pharmacology of amiodarone.

1 reference

12 December 2020

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

12 December 2020

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

12 December 2020

A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting

1 reference

12 December 2020

Ventricular defibrillation: appropriate energy levels

1 reference

12 December 2020

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

12 December 2020

Oral flecainide acetate for the treatment of ventricular arrhythmias

1 reference

12 December 2020

Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide

1 reference

12 December 2020

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

1 reference

12 December 2020

Differences between outward currents of human atrial and subepicardial ventricular myocytes

1 reference

12 December 2020

Restoration of sinus rhythm with flecainide in patients with atrial fibrillation

1 reference

12 December 2020

Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm

1 reference

12 December 2020

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

1 reference

12 December 2020

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

12 December 2020

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

12 December 2020

Role of catheter ablation for atrial fibrillation.

1 reference

12 December 2020

Cardioversion of supraventricular tachycardias.

1 reference

12 December 2020

Malignant ventricular tachyarrhythmias associated with the use of encainide

1 reference

12 December 2020

Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability

1 reference

12 December 2020

Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial

1 reference

12 December 2020

Chemical cardioversion of atrial fibrillation with intravenous dofetilide

1 reference

12 December 2020

Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial

1 reference

12 December 2020

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

1 reference

12 December 2020

Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources

1 reference

12 December 2020

The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure

1 reference

12 December 2020

Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil

1 reference

12 December 2020

A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction.

1 reference

12 December 2020

Supraventricular tachycardia

1 reference

12 December 2020

Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion

1 reference

12 December 2020

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

1 reference

12 December 2020

Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials

1 reference

12 December 2020

Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group

1 reference

12 December 2020

Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.

1 reference

12 December 2020

Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.

1 reference

12 December 2020

Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial

1 reference

12 December 2020

The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.

1 reference

12 December 2020

Clinical safety profile of sotalol in the treatment of arrhythmias

1 reference

12 December 2020

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

1 reference

12 December 2020

Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF)

1 reference

12 December 2020

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

1 reference

12 December 2020

Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm

1 reference

12 December 2020

Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications

1 reference

12 December 2020

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

12 December 2020

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators

1 reference

12 December 2020

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

1 reference

12 December 2020

Electrical remodeling in atrial fibrillation. Time course and mechanisms

1 reference

12 December 2020

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

1 reference

12 December 2020

Lack of effect of amiodarone on survival after extensive infarction. Polish Amiodarone Trial

1 reference

12 December 2020

International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group

1 reference

12 December 2020

The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

1 reference

12 December 2020

10.2165/00003495-199856050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1044753185

0 references

1 reference